VBI Vaccines Management
Management criteria checks 3/4
VBI Vaccines' CEO is Jeff Baxter, appointed in May 2016, has a tenure of 7.92 years. total yearly compensation is $1.83M, comprised of 37% salary and 63% bonuses, including company stock and options. directly owns 0.071% of the company’s shares, worth €10.66K. The average tenure of the management team and the board of directors is 6.6 years and 6.3 years respectively.
Key information
Jeff Baxter
Chief executive officer
US$1.8m
Total compensation
| CEO salary percentage | 37.0% |
| CEO tenure | 7.9yrs |
| CEO ownership | 0.07% |
| Management average tenure | 6.6yrs |
| Board average tenure | 6.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$94m |
| Sep 30 2023 | n/a | n/a | -US$115m |
| Jun 30 2023 | n/a | n/a | -US$119m |
| Mar 31 2023 | n/a | n/a | -US$120m |
| Dec 31 2022 | US$2m | US$678k | -US$113m |
| Sep 30 2022 | n/a | n/a | -US$111m |
| Jun 30 2022 | n/a | n/a | -US$102m |
| Mar 31 2022 | n/a | n/a | -US$73m |
| Dec 31 2021 | US$3m | US$605k | -US$70m |
| Sep 30 2021 | n/a | n/a | -US$66m |
| Jun 30 2021 | n/a | n/a | -US$63m |
| Mar 31 2021 | n/a | n/a | -US$56m |
| Dec 31 2020 | US$2m | US$535k | -US$46m |
| Sep 30 2020 | n/a | n/a | -US$42m |
| Jun 30 2020 | n/a | n/a | -US$45m |
| Mar 31 2020 | n/a | n/a | -US$49m |
| Dec 31 2019 | US$1m | US$500k | -US$55m |
| Sep 30 2019 | n/a | n/a | -US$63m |
| Jun 30 2019 | n/a | n/a | -US$62m |
| Mar 31 2019 | n/a | n/a | -US$66m |
| Dec 31 2018 | US$1m | US$465k | -US$64m |
| Sep 30 2018 | n/a | n/a | -US$56m |
| Jun 30 2018 | n/a | n/a | -US$50m |
| Mar 31 2018 | n/a | n/a | -US$43m |
| Dec 31 2017 | US$826k | US$450k | -US$39m |
Compensation vs Market: Jeff's total compensation ($USD1.83M) is above average for companies of similar size in the German market ($USD402.43K).
Compensation vs Earnings: Jeff's compensation has been consistent with company performance over the past year.
CEO
Jeff Baxter (62 yo)
7.9yrs
Tenure
US$1,830,436
Compensation
Mr. Jeffery R. Baxter, also known as Jeff, FCMA, has been the Chief Executive Officer and President of VBI Vaccines Inc. since May 2016. Mr. Baxter has been the Chief Executive Officer and President of VBI...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 7.9yrs | US$1.83m | 0.071% $ 10.7k | |
| Chief Scientific Officer | 7.9yrs | US$995.44k | 0.017% $ 2.6k | |
| Chief Medical Officer | 8.2yrs | US$1.01m | 0.049% $ 7.4k | |
| CFO, Head of Corporate Development & Director | less than a year | no data | 0.0080% $ 1.2k | |
| Director of Corporate Communications & Investor Relations | no data | no data | no data | |
| Senior VP of Finance | 6.6yrs | no data | no data | |
| Global Head of Manufacturing & GM of SciVac | 6.9yrs | no data | 0.025% $ 3.7k | |
| Senior VP of Global Commercial Supply Strategy & Head of Europe | 4.3yrs | no data | no data | |
| Senior Vice President of Business Development | 4.3yrs | no data | no data | |
| Chief Commercial Officer | 1.8yrs | no data | no data |
6.6yrs
Average Tenure
56.5yo
Average Age
Experienced Management: LO9A's management team is seasoned and experienced (6.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 7.9yrs | US$1.83m | 0.071% $ 10.7k | |
| CFO, Head of Corporate Development & Director | less than a year | no data | 0.0080% $ 1.2k | |
| Independent Chairperson of the Board | 7.9yrs | US$215.59k | 0.0099% $ 1.5k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 6.3yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Chairperson of the Commercial Advisory Board & Independent Director | 4.1yrs | US$139.88k | 0% $ 0 | |
| Independent Director and Chair of Scientific & Clinical Advisory Boards | 7.9yrs | US$132.33k | 0.0059% $ 876.0 | |
| Independent Director | 5.3yrs | US$144.83k | 0% $ 0 | |
| Independent Director | 5yrs | US$147.33k | 0% $ 0 | |
| Member of Scientific Advisory Board | 6.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 6.3yrs | no data | no data |
6.3yrs
Average Tenure
67yo
Average Age
Experienced Board: LO9A's board of directors are considered experienced (6.3 years average tenure).